Structure-activity relationship of memapsin 2: implications on physiological functions and Alzheimer's disease

Xiaoman Li1, Lin Hong, Kathleen Coughlan

  • 1Key Laboratory of Medical Cell Biology, Ministry of Education, China Medical University, Shenyang 110001, China.

Insights

Memapsin 2 (BACE1) cleaves amyloid precursor protein, producing amyloid beta linked to Alzheimer's disease. Its structure-function relationship and substrate specificity are key to understanding and inhibiting its role in disease pathogenesis.

Area of Science:

  • Biochemistry
  • Neuroscience
  • Molecular Biology

Background:

  • Memapsin 2 (BACE1) is a protease crucial for cleaving amyloid precursor protein (APP).
  • Amyloid beta (Aβ) production by BACE1 is implicated in Alzheimer's disease pathogenesis.
  • Understanding BACE1's function is vital for developing Alzheimer's disease therapeutics.

Purpose of the Study:

  • To review the structure-function relationship of memapsin 2 (BACE1).
  • To elucidate the catalytic activities and substrate specificity of BACE1.
  • To explore the role of BACE1 in Alzheimer's disease and inhibitor development.

Main Methods:

  • Analysis of the catalytic ectodomain structure and substrate-binding cleft.
  • Review of identified BACE1 substrates beyond APP.
  • Development of a predictive model for BACE1 cleavage efficiency.

Main Results:

  • The BACE1 substrate cleft accommodates 11 residues across distinct binding subsites.
  • A predictive model quantifies BACE1 cleavage efficiency for various substrates.
  • Knowledge of substrate specificity aids in understanding BACE1's biological roles.

Conclusions:

  • BACE1's structure dictates its substrate recognition and catalytic activity.
  • Predictive models enhance the study of BACE1's biological functions.
  • Further research into BACE1 is essential for Alzheimer's disease therapeutic strategies.

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Role of Neurotransmitters in Memory01:23

Role of Neurotransmitters in Memory

Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
 Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
The Periodic Table and Organismal Elements00:57

The Periodic Table and Organismal Elements

OverviewElements are the smallest units of matter that cannot be broken down further by chemical processes. There are 118 known elements, but not all of these are naturally-occurring, and fewer still are essential for life. Living matter is composed primarily of carbon, nitrogen, hydrogen, and oxygen, with smaller amounts of other elements like calcium, phosphorus, potassium, and sulfur. Other elements are also necessary for life but only in trace amounts.The Periodic Table Provides Information...